MicroRNA levels in patients with chronic hepatitis B virus and HIV coinfection in a high-prevalence setting; KwaZulu-Natal, South Africa | BMC Infectious Diseases

Alter HJ. To have B or not to have B: vaccine and the potential eradication of hepatitis B. J Hepatol. 2012;57(4):715–7.

PubMed 

Google Scholar 

Amponsah-Dacosta E. Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030? World J Gastroenterol. 2021;27(36):6025–38.

PubMed 
PubMed Central 

Google Scholar 

Liaw YF, Chu CM. Hepatitis B virus infection. Lancet (London, England). 2009;373(9663):582–92.

CAS 
PubMed 

Google Scholar 

Wu B, Yeh MM. Pathology of Hepatitis B Virus (HBV) Infection and HBV-Related Hepatocellular Carcinoma. In: Kao J-H, editor. Hepatitis B Virus and Liver Disease. Singapore: Springer Singapore; 2021. p. 99–122.

Google Scholar 

Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet (London, England). 2016;388(10049):1081–8.

PubMed 

Google Scholar 

Sheena BS, Hiebert L, Han H, Ippolito H, Abbasi-Kangevari M, Abbasi-Kangevari Z, et al. Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7(9):796–829.

Google Scholar 

WHO. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021: accountability for the global health sector strategies 2016–2021: actions for impact. 2021.

Google Scholar 

Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet (London, England). 2015;386(10003):1546–55.

PubMed 

Google Scholar 

Samsunder N, Ngcapu S, Lewis L, Baxter C, Cawood C, Khanyile D, et al. Seroprevalence of hepatitis B virus: Findings from a population-based household survey in KwaZulu-Natal, South Africa. Int J Infect Dis. 2019;85:150–7.

PubMed 
PubMed Central 

Google Scholar 

UNAIDS Global HIV & AIDS statistics – 2022 fact sheet. Accessed April 26, 2023 at http://www.unaids.org/en/resources/fact-sheet.

Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. J Clin Virol. 2006;35(1):14–20.

PubMed 

Google Scholar 

Msomi N, Naidoo K, Yende-Zuma N, Padayatchi N, Govender K, Singh JA, et al. High incidence and persistence of hepatitis B virus infection in individuals receiving HIV care in KwaZulu-Natal, South Africa. BMC Infect Dis. 2020;20(1):847.

PubMed 
PubMed Central 

Google Scholar 

Jin X, Cai C, Qiu Y. Diagnostic value of circulating microRNAs in hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis. J Cancer. 2019;10(20):4754–64.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–97.

CAS 
PubMed 

Google Scholar 

Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–33.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Yoshida T, Asano Y, Ui-Tei K. Modulation of MicroRNA processing by dicer via its associated dsRNA binding proteins. Non-Coding RNA. 2021;7(3):57.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843–54.

CAS 
PubMed 

Google Scholar 

Taganov KD, Boldin MP, Baltimore D. MicroRNAs and immunity: tiny players in a big field. Immunity. 2007;26(2):133–7.

CAS 
PubMed 

Google Scholar 

O’Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol. 2018;9:402.

CAS 

Google Scholar 

Lamontagne J, Steel LF, Bouchard MJ. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases. World J Gastroenterol. 2015;21(24):7375–99.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Liu WH, Yeh SH, Chen PJ. Role of microRNAs in hepatitis B virus replication and pathogenesis. Biochim Biophys Acta. 2011;1809(11):678–85.

CAS 
PubMed 

Google Scholar 

Sagnelli E, Potenza N, Onorato L, Sagnelli C, Coppola N, Russo A. Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma. World J Hepatol. 2018;10(9):558–70.

PubMed 
PubMed Central 

Google Scholar 

Naito Y, Hamada-Tsutsumi S, Yamamoto Y, Kogure A, Yoshioka Y, Watashi K, et al. Screening of microRNAs for a repressor of hepatitis B virus replication. Oncotarget. 2018;9(52):29857–68.

PubMed 
PubMed Central 

Google Scholar 

Yu F, Zhou G, Li G, Chen B, Dong P, Zheng J. Serum miR-181b is correlated with hepatitis B virus replication and disease progression in chronic hepatitis B patients. Dig Dis Sci. 2015;60(8):2346–52.

CAS 
PubMed 

Google Scholar 

Wu Y, Gao C, Cai S, Xia M, Liao G, Zhang X, et al. Circulating miR-122 is a predictor for virological response in CHB patients with high viral load treated with nucleos
PubMed 
PubMed Central 

Google Scholar 

Tan B, Liu M, Wang L, Wang J, Xiong F, Bao X, et al. Serum microRNAs predict response of patients with chronic hepatitis B to antiviral therapy. Int J Infect Dis. 2021;108:37–44.

CAS 
PubMed 

Google Scholar 

Maepa MB, Ely A, Kramvis A, Bloom K, Naidoo K, Simani OE, et al. Hepatitis B virus research in South Africa. Viruses. 2022;14(9):1939.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–99.

PubMed 

Google Scholar 

Chen C, Tan R, Wong L, Fekete R, Halsey J. Quantitation of microRNAs by real-time RT-qPCR. Methods Mol Biol. 2011;687:113–34.

CAS 
PubMed 

Google Scholar 

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–8.

CAS 
PubMed 

Google Scholar 

Thissen D, Steinberg L, Kuang D. Quick and Easy Implementation of the Benjamini-Hochberg Procedure for Controlling the False Positive Rate in Multiple Comparisons. J Educ Behav Stat. 2002;27(1):77–83.

Zoulim F, Locarnini S. Hepatitis B virus resistance to nucleos
PubMed 

Google Scholar 

Orrell C, Kaplan R, Wood R, Bekker LG. Virological breakthrough: a risk factor for loss to followup in a large community-based cohort on antiretroviral therapy. AIDS Res Treat. 2011;2011:469127.

PubMed 
PubMed Central 

Google Scholar 

Winther TN, Bang-Berthelsen CH, Heiberg IL, Pociot F, Hogh B. Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B. PLoS One. 2013;8(3):e58236.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Huang C, Zheng JM, Cheng Q, Yu KK, Ling QX, Chen MQ, et al. Serum microRNA-29 levels correlate with disease progression in patients with chronic hepatitis B virus infection. J Dig Dis. 2014;15(11):614–21.

CAS 
PubMed 

Google Scholar 

van der Ree MH, Jansen L, Kruize Z, van Nuenen AC, van Dort KA, Takkenberg RB, et al. Plasma MicroRNA levels are associated with hepatitis B e antigen status and treatment response in chronic hepatitis B patients. J Infect Dis. 2017;215(9):1421–9.

PubMed 

Google Scholar 

Yousefpouran S, Mostafaei S, Manesh PV, Iranifar E, Bokharaei-Salim F, Nahand JS, et al. The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV Co-infection and elite controllers for determination of biomarker. Microb Pathog. 2020;147:104355.

CAS 
PubMed 

Google Scholar 

National Department of Health. National guidelines for the management of viral hepatitis. South Africa: NDOH; 2020. Available from: https://knowledgehub.health.gov.za/elibrary/national-guidelines-management-viral-hepatitis.

Coffin CS, Zhou K, Terrault NA. New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Virus Infection. Gastroenterology. 2019;156(2):355-68.e3.

CAS 
PubMed 

Google Scholar 

Kramvis A, Chang K-M, Dandri M, Farci P, Glebe D, Hu J, et al. A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook. Nat Rev Gastroenterol Hepatol. 2022;19(11):727–45.

PubMed 
PubMed Central 

Google Scholar 

Wang TZ, Lin DD, Jin BX, Sun XY, Li N. Plasma microRNA: A novel non-invasive biomarker for HBV-associated liver fibrosis staging. Exp Ther Med. 2019;17(3):1919–29.

CAS 
PubMed 

Google Scholar 

Bonino F, Piratvisuth T, Brunetto MR, Liaw YF. Diagnostic markers of chronic hepatitis B infection and disease. Antivir Ther. 2010;15(Suppl 3):35–44.

CAS 
PubMed 

Google Scholar 

Gümüşay O, Ozenirler S, Atak A, Sönmez C, Ozkan S, Tuncel AF, et al. Diagnostic potential of serum direct markers and non-invasive fibrosis models in patients with chronic hepatitis B. Hepatol Res. 2013;43(3):228–37.

PubMed 

Google Scholar 

Peng C, Li Z, Xie Z, Wang Z, Ye Y, Li B, et al. The role of circulating microRNAs for the diagnosis of hepatitis B virus-associated hepatocellular carcinoma with low alpha-fetoprotein level: a systematic review and meta-analysis. BMC Gastroenterol. 2020;20(1):249.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Sartorius K, Makarova J, Sartorius B, An P, Winkler C, Chuturgoon A, et al. The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis. Cells. 2019;8:1504. https://doi.org/10.3390/cells8121504.(12).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Li F, Zhou P, Deng W, Wang J, Mao R, Zhang Y, et al. Serum microRNA-125b correlates with hepatitis B viral replication and liver necroinflammation. Clin Microbiol Infect. 2016;22(4):384.e1-.e10.

CAS 
PubMed 

Google Scholar 

Firnhaber C, Reyneke A, Schulze D, Malope B, Maskew M, MacPhail P, et al. The prevalence of hepatitis B co-infection in a South African urban government HIV clinic. S Afr Med J. 2008;98(7):541–4.

PubMed 
PubMed Central 

Google Scholar 

Boyles TH, Cohen K. The prevalence of hepatitis B infection in a rural South African HIV clinic. S Afr Med J. 2011;101(7):470–1.

PubMed 

Google Scholar 

Kramvis A. Molecular characteristics and clinical relevance of African genotypes and subgenotypes of hepatitis B virus. S Afr Med J. 2018;108(8b):17–21.

CAS 
PubMed 

Google Scholar 

Kew MC, Kramvis A, Yu MC, Arakawa K, Hodkinson J. Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu-speaking sub-saharan Africans. J Med Virol. 2005;75(4):513–21.

CAS 
PubMed 

Google Scholar 

Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z, et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol. 2011;29(36):4781–8.

CAS 
PubMed 

Google Scholar 

Zhang X, Chen C, Wu M, Chen L, Zhang J, Zhang X, et al. Plasma microRNA profile as a predictor of early virological response to interferon treatment in chronic hepatitis B patients. Antivir Ther. 2012;17(7):1243–53.

CAS 
PubMed 

Google Scholar 

Liu CJ, Kao JH. Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to. J Seminars Liver Dis. 2013;33(2):97–102.

Google Scholar 

Elizalde MM, Tadey L, Mammana L, Quarleri JF, Campos RH, Flichman DM. Biological characterization of hepatitis B virus genotypes: their role in viral replication and antigen expression. Front Microbiol. 2021;12:758613.

PubMed 
PubMed Central 

Google Scholar 

Ito K, Yotsuyanagi H, Yatsuhashi H, Karino Y, Takikawa Y, Saito T, et al. Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults. Hepatology. 2014;59(1):89–97.

CAS 
PubMed 

Google Scholar 

Carman W, Hadziyannis S, McGarvey M, Jacyna M, Karayiannis P, Makris A, et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet. 1989;334(8663):588–91.

Google Scholar 

Zhang J, Xu WJ, Wang Q, Zhang Y, Shi M. Prevalence of the precore G1896A mutation in Chinese patients with e antigen negative hepatitis B virus infection and its relationship to pre-S1 antigen. Bras J Microbiol. 2009;40(4):965–71.

CAS 

Google Scholar 

Witwer KW, Watson AK, Blankson JN, Clements JE. Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients. Retrovirology. 2012;9:5.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Moghoofei M, Bokharaei-Salim F, Esghaei M, Keyvani H, Honardoost M, Mostafaei S, et al. microRNAs 29, 150, 155, 223 level and their relation to viral and immunological markers in HIV-1 infected naive patients. Futur Virol. 2018;13(9):637–45.

CAS 

Google Scholar 

Sartorius K, Sartorius B, Kramvis A, Singh E, Turchinovich A, Burwinkel B, et al. Circulating microRNA’s as a diagnostic tool for hepatocellular carcinoma in a hyper endemic HIV setting, KwaZulu-Natal, South Africa: a case control study protocol focusing on viral etiology. BMC Cancer. 2017;17(1):894.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Sartorius K, Makarova J, Sartorius B, An P, Winkler C, Chuturgoon A, et al. The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis. Cells. 2019;8(12):1504.

CAS 
PubMed 
PubMed Central 

Google Scholar